กระดานเทรด: Frankfurt หมวดธุรกิจ: การดูแลสุขภาพ อุตสาหกรรม: เทคโนโลยีชีวภาพ ตลาดหุ้น - โควตและราคา
รายชื่อหุ้นและตราสารทุนทั้งหมดพร้อมราคา มูลค่าตามราคาตลาด PE และ EPS
ประเทศทั้งหมด
- {{country.name}}
- ประเทศทั้งหมด
- เยอรมนี (648)
Frankfurt (648)
- {{item.name}}
- กระดานเทรดทั้งหมด
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (289)
- NasdaqGM (143)
- NasdaqGS (218)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (119)
- OTC Markets OTCPK (134)
- OTC Markets OTCQB (33)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (45)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
การดูแลสุขภาพ (648)
- {{item.name}}
- หมวดธุรกิจทั้งหมด
- การดูแลสุขภาพ (648)
เทคโนโลยีชีวภาพ (648)
- {{item.name}}
- อุตสาหกรรมทั้งหมด
- เทคโนโลยีชีวภาพ (648)
- ผู้ผลิตยา - ทั่วไป (45)
- ผู้ผลิตยา - เฉพาะทางและทั่วไป (277)
- แผนการดูแลสุขภาพ (9)
- สิ่งอำนวยความสะดวกการดูแลทางการแพทย์ (93)
- ผู้ค้าปลีกเภสัชภัณฑ์ (21)
- บริการข้อมูลด้านสุขภาพ (81)
- อุปกรณ์ทางการแพทย์ (202)
- เครื่องมือและอุปกรณ์ทางการแพทย์ (106)
- การวินิจฉัยและการวิจัย (102)
- การจำหน่ายทางการแพทย์ (22)
| ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS |
|---|
| ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.6099 0.67 USD |
+3.57
|
$11.23B 12.28B USD | $17.35K 18.97K USD | $0.5899 0.64 USD | $0.6099 0.67 USD | $11.23B 12.28B USD | 61.00 | $0.01 0.01 USD | |
| CureVac N.V. 5CV.F | $4.6 5.03 USD |
+0.44
|
$1.05B 1.14B USD | $10.51K 11.48K USD | $4.58 5 USD | $4.63 5.07 USD | $1.05B 1.14B USD | 5.75 | $0.8 0.87 USD | |
| Valneva SE AYJ.F | $2.4 2.63 USD |
-4.68
|
$408.83M 446.91M USD | $6.62K 7.24K USD | $2.39 2.62 USD | $2.52 2.76 USD | $408.83M 446.91M USD | 0 | -$0.56 -0.6 USD | |
| Ocugen, Inc. 2H51.F | $0.8199 0.89 USD |
+1.95
|
$242.06M 264.6M USD | $4.7K 5.14K USD | $0.8 0.87 USD | $0.8199 0.9 USD | $242.06M 264.6M USD | 0 | -$0.17 -0.1 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| Immunic, Inc. 10VA.F | $0.66 0.72 USD |
+7.52
|
$63.65M 69.57M USD | $1K 1.09K USD | $0.6199 0.67 USD | $0.66 0.72 USD | $63.65M 69.57M USD | 0 | -$0.81 -0.8 USD | |
| Alterity Therapeutics Limited PBN.F | $0.004 0.0043 USD |
0
|
$49.63M 54.25M USD | $120K 131.18K USD | $0.004 0.0043 USD | $0.004 0.0043 USD | $49.63M 54.25M USD | 0 | $0 0 USD | |
| Actinogen Medical Limited 3AC.F | $0.02 0.02 USD |
-13.89
|
$49.25M 53.83M USD | $477.71K 522.21K USD | $0.02 0.02 USD | $0.02 0.02 USD | $49.25M 53.83M USD | 0 | $0 0 USD | |
| Defence Therapeutics Inc. DTC.F | $0.46 0.5 USD |
+11.38
|
$27.85M 30.44M USD | $8.4K 9.18K USD | $0.4099 0.45 USD | $0.46 0.5 USD | $27.85M 30.44M USD | 0 | -$0.05 -0.05 USD | |
| Active Biotech AB (publ) BTPC.F | $0.01 0.02 USD |
+4.23
|
$22.09M 24.15M USD | $50.4K 55.09K USD | $0.01 0.02 USD | $0.01 0.02 USD | $22.09M 24.15M USD | 0 | -$0.01 -0.01 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
0
|
$6.43M 7.03M USD | $45K 49.19K USD | $0.01 0.01 USD | $0.01 0.01 USD | $6.43M 7.03M USD | 0 | -$0.01 -0.01 USD | |
| Memphasys Limited IG7.F | $0.002 0.0021 USD |
0
|
$5.54M 6.06M USD | $364.25K 398.17K USD | $0.002 0.0021 USD | $0.002 0.0021 USD | $5.54M 6.06M USD | 0 | $0 0 USD | |
| Glow Lifetech Corp. 9DO.F | $0.02 0.02 USD |
-7.5
|
$4.92M 5.38M USD | $1K 1.09K USD | $0.02 0.02 USD | $0.02 0.02 USD | $4.92M 5.38M USD | 0 | -$0.02 -0.02 USD | |
| Medigene AG MDG1.F | $0.14 0.15 USD |
+1.44
|
$2.07M 2.26M USD | $375 409.93 USD | $0.14 0.15 USD | $0.1499 0.16 USD | $2.07M 2.26M USD | 0 | -$1.21 -1.3 USD | |
| BioSenic S.A. BT1.F | $0.0022 0.0024 USD |
+10
|
$1.72M 1.88M USD | $459 501.75 USD | $0.0022 0.0024 USD | $0.0022 0.0024 USD | $1.72M 1.88M USD | 0 | -$0.04 -0.04 USD | |
| Novo Nordisk A/S NOVA.F | $58.6 64.06 USD |
-2.01
|
$263.37B 287.9B USD | $1.28K 1.4K USD | $58.6 64.06 USD | $61 66.68 USD | $263.37B 287.9B USD | 18.60 | $3.15 3.44 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $390.8 427.2 USD |
+0.53
|
$100.8B 110.19B USD | $50 54.66 USD | $388.95 425.17 USD | $390.8 427.2 USD | $100.8B 110.19B USD | 0 | -$3.23 -3.5 USD | |
| CSL Limited CSJ.F | $135.28 147.88 USD |
+1.44
|
$66.62B 72.83B USD | $100 109.31 USD | $135.26 147.86 USD | $135.28 147.88 USD | $66.62B 72.83B USD | 29.21 | $4.63 5.06 USD | |
| CSL Limited CSJA.F | $66.5 72.69 USD |
+0.76
|
$66.18B 72.34B USD | $5 5.47 USD | $66.5 72.69 USD | $66.5 72.69 USD | $66.18B 72.34B USD | 28.66 | $2.32 2.54 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $276.5 302.25 USD |
-0.25
|
$36.67B 40.09B USD | $375 409.93 USD | $276.5 302.25 USD | $276.5 302.25 USD | $36.67B 40.09B USD | 0 | -$1.77 -1.9 USD | |
| UCB SA UNC0.F | $83.5 91.28 USD |
+4.38
|
$33.5B 36.62B USD | $50 54.66 USD | $83.5 91.28 USD | $83.5 91.28 USD | $33.5B 36.62B USD | 30.47 | $2.74 3 USD | |
| UCB SA UNC.F | $169.5 185.29 USD |
+4.28
|
$33.47B 36.59B USD | $310 338.87 USD | $169.5 185.29 USD | $169.5 185.29 USD | $33.47B 36.59B USD | 30.93 | $5.48 5.99 USD | |
| argenx SE 1AE.F | $467.1 510.6 USD |
+1.17
|
$28.85B 31.54B USD | $9 9.84 USD | $467.1 510.6 USD | $467.1 510.6 USD | $28.85B 31.54B USD | 33.50 | $13.94 15.24 USD | |
| argenx SE 1AEA.F | $454 496.28 USD |
-0.44
|
$28.4B 31.04B USD | $12 13.12 USD | $454 496.28 USD | $454 496.28 USD | $28.4B 31.04B USD | 32.54 | $13.95 15.25 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
0
|
$25.73B 28.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $25.73B 28.13B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49BA.F | $208 227.37 USD |
-0.95
|
$23.67B 25.87B USD | $10 10.93 USD | $208 227.37 USD | $208 227.37 USD | $23.67B 25.87B USD | 0 | -$3.09 -3.3 USD | |
| BioNTech SE 22UA.F | $94.65 103.47 USD |
+0.42
|
$22.75B 24.87B USD | $616 673.37 USD | $93.2 101.88 USD | $94.9 103.74 USD | $22.75B 24.87B USD | 0 | -$3.19 -3.4 USD | |
| Royalty Pharma plc RPD.F | $30.55 33.4 USD |
+0.23
|
$17.41B 19.03B USD | $114 124.62 USD | $30.55 33.4 USD | $30.55 33.4 USD | $17.41B 19.03B USD | 14.68 | $2.08 2.27 USD | |
| Insmed Incorporated IM8N.F | $82.5 90.18 USD |
+0.61
|
$15.88B 17.36B USD | $550 601.22 USD | $82.5 90.18 USD | $82.5 90.18 USD | $15.88B 17.36B USD | 0 | -$5.03 -5.4 USD | |
| Innovent Biologics, Inc. 6IB.F | $8.8 9.62 USD |
-6.38
|
$14.42B 15.76B USD | $1.06K 1.16K USD | $8.75 9.56 USD | $9.1 9.95 USD | $14.42B 15.76B USD | 0 | -$0.01 -0.01 USD | |
| Incyte Corporation ICY.F | $58.34 63.77 USD |
-0.07
|
$11.29B 12.34B USD | $198 216.44 USD | $58.34 63.77 USD | $58.34 63.77 USD | $11.29B 12.34B USD | 343.17 | $0.17 0.19 USD | |
| United Therapeutics Corporation UTH.F | $248.3 271.43 USD |
0
|
$11.29B 12.34B USD | $18 19.68 USD | $248.3 271.43 USD | $248.3 271.43 USD | $11.29B 12.34B USD | 11.64 | $21.33 23.32 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.68 2.93 USD |
-3.71
|
$11.11B 12.15B USD | $264 288.59 USD | $2.67 2.92 USD | $2.68 2.93 USD | $11.11B 12.15B USD | 29.74 | $0.09 0.1 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.3 5.79 USD |
-4.5
|
$11.02B 12.05B USD | $208 227.37 USD | $5.3 5.79 USD | $5.3 5.79 USD | $11.02B 12.05B USD | 29.44 | $0.18 0.2 USD | |
| Exelixis, Inc. EX9.F | $39.58 43.27 USD |
+2.27
|
$10.94B 11.95B USD | $1.11K 1.22K USD | $38.69 42.29 USD | $39.58 43.27 USD | $10.94B 11.95B USD | 21.27 | $1.86 2.03 USD | |
| Akeso, Inc. 4RY.F | $12.1 13.23 USD |
-3.2
|
$10.92B 11.94B USD | $320 349.8 USD | $12.1 13.23 USD | $12.1 13.23 USD | $10.92B 11.94B USD | 0 | -$0.07 -0.07 USD | |
| Verona Pharma plc I9SA.F | $79.8 87.23 USD |
+5
|
$10.86B 11.87B USD | $90 98.38 USD | $77 84.17 USD | $79.8 87.23 USD | $10.86B 11.87B USD | 0 | -$1.7 -1.8 USD | |
| Moderna, Inc. 0QF.F | $25.75 28.15 USD |
-0.96
|
$9.96B 10.89B USD | $212 231.74 USD | $25.75 28.15 USD | $26.15 28.58 USD | $9.96B 10.89B USD | 0 | -$7.42 -8.1 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.67 53.2 USD |
+0.02
|
$9.37B 10.24B USD | $35 38.26 USD | $48.67 53.2 USD | $48.67 53.2 USD | $9.37B 10.24B USD | 21.25 | $2.29 2.5 USD | |
| Ascendis Pharma A/S A71.F | $146 159.6 USD |
0
|
$8.95B 9.79B USD | $1 1.09 USD | $146 159.6 USD | $146 159.6 USD | $8.95B 9.79B USD | 0 | -$5.81 -6.3 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| Blueprint Medicines Corporation 2L9.F | $109.2 119.37 USD |
+1.53
|
$7.16B 7.83B USD | $279 304.98 USD | $107.75 117.79 USD | $109.25 119.43 USD | $7.16B 7.83B USD | 0 | -$2.13 -2.3 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $36.98 40.42 USD |
+0.14
|
$7.11B 7.77B USD | $25 27.33 USD | $36.98 40.42 USD | $36.98 40.42 USD | $7.11B 7.77B USD | 0 | -$3.02 -3.3 USD | |
| Bio-Techne Corporation TE1.F | $43.2 47.22 USD |
-2.7
|
$6.89B 7.53B USD | $150 163.97 USD | $43.2 47.22 USD | $45.2 49.41 USD | $6.89B 7.53B USD | 60.84 | $0.71 0.78 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $20 21.86 USD |
-2.44
|
$6.8B 7.44B USD | $1 1.09 USD | $20 21.86 USD | $20.2 22.08 USD | $6.8B 7.44B USD | 0 | -$4.29 -4.6 USD | |
| 3SBio Inc. 83B.F | $2.68 2.93 USD |
-2.19
|
$6.35B 6.94B USD | $1.81K 1.98K USD | $2.64 2.89 USD | $2.68 2.93 USD | $6.35B 6.94B USD | 26.80 | $0.1 0.11 USD | |
| Roivant Sciences Ltd. 87S.F | $9.18 10.03 USD |
-0.17
|
$6.34B 6.93B USD | $600 655.88 USD | $9.18 10.03 USD | $9.22 10.08 USD | $6.34B 6.93B USD | 0 | -$0.64 -0.6 USD | |
| Corcept Therapeutics Incorporated HTD.F | $57.72 63.1 USD |
-4.18
|
$6.24B 6.82B USD | $10 10.93 USD | $57.72 63.1 USD | $60.64 66.29 USD | $6.24B 6.82B USD | 58.89 | $0.98 1.07 USD | |
| Financière de Tubize SA FTD.F | $133.2 145.61 USD |
+3.74
|
$6.19B 6.76B USD | $70 76.52 USD | $133.2 145.61 USD | $133.2 145.61 USD | $6.19B 6.76B USD | 65.61 | $2.03 2.22 USD | |
| Revolution Medicines, Inc. 42Z.F | $31.8 34.76 USD |
0
|
$5.99B 6.55B USD | $100 109.31 USD | $31.8 34.76 USD | $31.8 34.76 USD | $5.99B 6.55B USD | 0 | -$3.41 -3.7 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $36.63 40.04 USD |
+0.96
|
$5.87B 6.42B USD | $145 158.5 USD | $36.63 40.04 USD | $36.63 40.04 USD | $5.87B 6.42B USD | 0 | -$2.54 -2.7 USD | |
| ALK-Abelló A/S 4AJ0.F | $25.1 27.44 USD |
+1.29
|
$5.7B 6.24B USD | $5 5.47 USD | $25.1 27.44 USD | $25.3 27.66 USD | $5.7B 6.24B USD | 44.82 | $0.56 0.61 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $45.62 49.87 USD |
-0.37
|
$5.63B 6.16B USD | $321 350.9 USD | $45.62 49.87 USD | $45.62 49.87 USD | $5.63B 6.16B USD | 14.25 | $3.2 3.5 USD | |
| Legend Biotech Corporation 9LB.F | $30.6 33.45 USD |
+0.66
|
$5.63B 6.16B USD | $140 153.04 USD | $29.8 32.58 USD | $30.6 33.45 USD | $5.63B 6.16B USD | 0 | -$1 -1.09 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $91.62 100.15 USD |
-0.15
|
$5.62B 6.14B USD | $10 10.93 USD | $91.62 100.15 USD | $92.1 100.68 USD | $5.62B 6.14B USD | 14.65 | $6.25 6.83 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $246.3 269.24 USD |
-1.76
|
$5.54B 6.05B USD | $17 18.58 USD | $243.9 266.62 USD | $251.7 275.14 USD | $5.54B 6.05B USD | 0 | -$15.16 -16.5 USD | |
| TG Therapeutics, Inc. NKB2.F | $30.85 33.72 USD |
+0.08
|
$4.96B 5.42B USD | $300 327.94 USD | $30.85 33.72 USD | $30.85 33.72 USD | $4.96B 5.42B USD | 146.90 | $0.21 0.23 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $88.7 96.96 USD |
+0.05
|
$4.41B 4.82B USD | $40 43.73 USD | $88.3 96.52 USD | $90.52 98.95 USD | $4.41B 4.82B USD | 0 | -$4.9 -5.3 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $8.65 9.46 USD |
-2.81
|
$3.66B 4B USD | $971 1.06K USD | $8.65 9.46 USD | $8.65 9.46 USD | $3.66B 4B USD | 26.21 | $0.33 0.36 USD | |
| Vaxcyte, Inc. 5VA.F | $26.8 29.3 USD |
0
|
$3.64B 3.98B USD | $100 109.31 USD | $26.8 29.3 USD | $26.8 29.3 USD | $3.64B 3.98B USD | 0 | -$3.39 -3.7 USD | |
| Krystal Biotech, Inc. 4KB.F | $123.5 135 USD |
+2.53
|
$3.6B 3.94B USD | $114 124.62 USD | $120.35 131.56 USD | $123.5 135 USD | $3.6B 3.94B USD | 34.88 | $3.54 3.87 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $55.5 60.67 USD |
+0.91
|
$3.59B 3.92B USD | $20 21.86 USD | $55.5 60.67 USD | $55.5 60.67 USD | $3.59B 3.92B USD | 0 | -$2.38 -2.6 USD | |
| Akero Therapeutics, Inc. 0K4.F | $43.59 47.65 USD |
+0.07
|
$3.51B 3.84B USD | $47 51.38 USD | $43.59 47.65 USD | $43.59 47.65 USD | $3.51B 3.84B USD | 0 | -$3.18 -3.4 USD | |
| Camurus AB (publ) 7CA.F | $57.55 62.91 USD |
+3.04
|
$3.51B 3.83B USD | $43 47 USD | $57.55 62.91 USD | $57.55 62.91 USD | $3.51B 3.83B USD | 70.18 | $0.82 0.9 USD | |
| Genscript Biotech Corporation G51.F | $1.55 1.69 USD |
-2.62
|
$3.47B 3.79B USD | $2.77K 3.03K USD | $1.55 1.69 USD | $1.55 1.69 USD | $3.47B 3.79B USD | 0 | -$0.07 -0.07 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Merus N.V. 2GH.F | $44.8 48.97 USD |
+0.45
|
$3.42B 3.74B USD | $106 115.87 USD | $44.6 48.75 USD | $44.8 48.97 USD | $3.42B 3.74B USD | 0 | -$3.53 -3.8 USD | |
| Cytokinetics, Incorporated KK3A.F | $27.8 30.39 USD |
-2.8
|
$3.42B 3.74B USD | $150 163.97 USD | $27.8 30.39 USD | $29.2 31.92 USD | $3.42B 3.74B USD | 0 | -$4.49 -4.9 USD | |
| Zai Lab Limited 1ZL.F | $30 32.79 USD |
-1.32
|
$3.35B 3.67B USD | $230 251.42 USD | $30 32.79 USD | $30 32.79 USD | $3.35B 3.67B USD | 0 | -$2.12 -2.3 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $33.4 36.51 USD |
-1.18
|
$3.17B 3.46B USD | $400 437.25 USD | $33.4 36.51 USD | $33.4 36.51 USD | $3.17B 3.46B USD | 0 | -$4.95 -5.4 USD | |
| Ascentage Pharma Group International 36X.F | $8.75 9.56 USD |
-3.31
|
$3.09B 3.38B USD | $174 190.21 USD | $8.75 9.56 USD | $8.85 9.67 USD | $3.09B 3.38B USD | 0 | -$0.16 -0.1 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $17.61 19.25 USD |
-0.03
|
$2.98B 3.26B USD | $100 109.31 USD | $17.61 19.25 USD | $17.61 19.25 USD | $2.98B 3.26B USD | 15.18 | $1.16 1.27 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $56.3 61.54 USD |
+1.44
|
$2.92B 3.19B USD | $80 87.45 USD | $56.3 61.54 USD | $56.3 61.54 USD | $2.92B 3.19B USD | 20.62 | $2.73 2.98 USD | |
| Scholar Rock Holding Corporation 2QK.F | $30.2 33.01 USD |
0
|
$2.9B 3.17B USD | $50 54.66 USD | $30.2 33.01 USD | $30.2 33.01 USD | $2.9B 3.17B USD | 0 | -$2.17 -2.3 USD | |
| Viking Therapeutics, Inc. 1VT.F | $23.95 26.18 USD |
-0.95
|
$2.69B 2.94B USD | $413 451.46 USD | $23.6 25.8 USD | $24.6 26.89 USD | $2.69B 2.94B USD | 0 | -$0.99 -1.08 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Everest Medicines Limited 6HN.F | $7.1 7.76 USD |
-0.7
|
$2.34B 2.56B USD | $12 13.12 USD | $7.1 7.76 USD | $7.1 7.76 USD | $2.34B 2.56B USD | 0 | -$0.38 -0.4 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $24.6 26.89 USD |
-2.38
|
$2.32B 2.53B USD | $40 43.73 USD | $24.6 26.89 USD | $24.6 26.89 USD | $2.32B 2.53B USD | 0 | -$3.23 -3.5 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $17.81 19.47 USD |
+0.34
|
$2.23B 2.44B USD | $700 765.19 USD | $17.81 19.47 USD | $17.81 19.47 USD | $2.23B 2.44B USD | 13.39 | $1.33 1.45 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $27.8 30.39 USD |
0
|
$2.17B 2.37B USD | $100 109.31 USD | $27.8 30.39 USD | $27.8 30.39 USD | $2.17B 2.37B USD | 0 | -$2.74 -2.9 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $41.2 45.04 USD |
0
|
$2.12B 2.31B USD | $26 28.42 USD | $41.2 45.04 USD | $41.6 45.47 USD | $2.12B 2.31B USD | 0 | -$1.37 -1.4 USD | |
| ImmunityBio, Inc. 26CA.F | $2.32 2.53 USD |
-10.85
|
$2.05B 2.24B USD | $1K 1.09K USD | $2.31 2.53 USD | $2.56 2.8 USD | $2.05B 2.24B USD | 0 | -$0.48 -0.5 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.1 16.51 USD |
+2.39
|
$2B 2.18B USD | $680 743.33 USD | $15.1 16.51 USD | $15.1 16.51 USD | $2B 2.18B USD | 0 | -$1.53 -1.6 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $14.18 15.5 USD |
+0.46
|
$1.98B 2.16B USD | $700 765.19 USD | $14.18 15.5 USD | $14.18 15.5 USD | $1.98B 2.16B USD | 0 | -$1.05 -1.1 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $96.5 105.49 USD |
0
|
$1.88B 2.05B USD | $20 21.86 USD | $96.5 105.49 USD | $96.5 105.49 USD | $1.88B 2.05B USD | 0 | -$6.2 -6.7 USD | |
| Veracyte, Inc. 12V.F | $23.4 25.58 USD |
0
|
$1.83B 2B USD | $250 273.28 USD | $23.4 25.58 USD | $23.4 25.58 USD | $1.83B 2B USD | 65.00 | $0.36 0.39 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.24 13.37 USD |
+0.74
|
$1.83B 2B USD | $230 251.42 USD | $12.07 13.19 USD | $12.24 13.37 USD | $1.83B 2B USD | 0 | -$2.27 -2.4 USD | |
| Vericel Corporation ATQP.F | $34.4 37.6 USD |
-0.58
|
$1.77B 1.94B USD | $3 3.28 USD | $34.4 37.6 USD | $34.4 37.6 USD | $1.77B 1.94B USD | 860.00 | $0.04 0.04 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $30.2 33.01 USD |
0
|
$1.77B 1.94B USD | $120 131.18 USD | $30.2 33.01 USD | $30.2 33.01 USD | $1.77B 1.94B USD | 3.08 | $9.8 10.71 USD | |
| BB Biotech AG BBZA.F | $32 34.98 USD |
-1.39
|
$1.77B 1.93B USD | $300 327.94 USD | $32 34.98 USD | $32.7 35.75 USD | $1.77B 1.93B USD | 0 | -$8.31 -9.08 USD | |
| Bavarian Nordic A/S BV3.F | $22.38 24.46 USD |
-2.27
|
$1.76B 1.93B USD | $232 253.61 USD | $22.38 24.46 USD | $22.91 25.04 USD | $1.76B 1.93B USD | 9.94 | $2.25 2.46 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $18.7 20.44 USD |
0
|
$1.64B 1.8B USD | $150 163.97 USD | $18.7 20.44 USD | $18.7 20.44 USD | $1.64B 1.8B USD | 0 | -$3.1 -3.3 USD | |
| Oxford Nanopore Technologies plc 4R0.F | $1.67 1.82 USD |
-0.95
|
$1.63B 1.79B USD | $25K 27.33K USD | $1.65 1.8 USD | $1.76 1.92 USD | $1.63B 1.79B USD | 0 | -$0.19 -0.2 USD | |
| Galapagos NV GXEA.F | $24.4 26.67 USD |
+0.83
|
$1.63B 1.78B USD | $2 2.19 USD | $24.4 26.67 USD | $24.4 26.67 USD | $1.63B 1.78B USD | 0 | -$2.73 -2.9 USD | |
|
ไม่มีหุ้นที่ชื่นชอบ
คุณยังไม่มีหุ้นที่ชื่นชอบ กรุณาเพิ่มลงในรายการโปรดเพื่อดูที่นี่ |
||||||||||